ConferenceAmerican Journal of Respiratory and Critical Care Medicine · May 1, 2026
AbstractRationaleProgressive pulmonary fibrosis (PPF) describes a subset of patients with interstitial lung disease (ILD) other ...
Full textCite
ConferenceAmerican Journal of Respiratory and Critical Care Medicine · May 1, 2026
AbstractRationalePatients with interstitial lung disease related to systemic autoimmune rheumatic diseases (SARD-ILD) may devel ...
Full textCite
ConferenceAmerican Journal of Respiratory and Critical Care Medicine · May 1, 2025
AbstractRationale: Clinical trials of antifibrotic therapies, nintedanib and pirfenidone, demonstrate a reduction in lung function decline in patients with idiopathic pulmonary fibrosis (IPF). However, bo ...
Full textCite
ConferenceCirculation · November 7, 2023
Introduction:
Elevated body mass index (BMI) is a risk factor for cardiovascular (CV) events. It remains unclear if the effectiveness and safety of aspirin dose (81mg vs 325mg) is modified by baseline ...
Full textCite
ConferenceAm Heart J · September 2023
BACKGROUND: Electronic health record (EHR)-based identification of heart failure with preserved ejection fraction (HFpEF) in the clinical setting may facilitate screening for clinical trials by improving the understanding of its epidemiology and outcomes; ...
Full textLink to itemCite
ConferenceStroke · March 2021
Background:
Ischemic Stroke (IS) is associated with an increased risk of dementia, but the relative contribution of IS severity or recurrence to cognition is not known. We aimed to determine the risk ...
Full textCite
ConferenceStroke · November 2014
BACKGROUND AND PURPOSE: Characterizing International Classification of Disease 9th Revision, Clinical Modification (ICD-9-CM) code validity is essential given widespread use of hospital discharge databases in research. Using the Atherosclerosis Risk in Com ...
Full textLink to itemCite